Background
Venlafaxine (selective serotonin and norepinephrine reuptake inhibitor) use has increased worldwide. However, the impact of venlafaxine on testes and sperm parameters has not been investigated.
Objectives
We evaluated venlafaxine impact on testicular and sperm parameters and verified whether the changes are reversible.
Methods
Animals from venlafaxine‐35 days and venlafaxine‐65 days groups received 30 mg/kg of venlafaxine for 35 days. Control‐35 days and control‐65 days received distilled water. In control‐65 days and venlafaxine‐65 days, the treatment was interrupted for 30 days. Sperm concentration, morphology, motility, and mitochondrial activity were analyzed. Number of step 19 spermatids (NLS), frequency of tubules with spermiation failure, Sertoli cells number, and TUNEL‐positive germ cells were quantified. Testicular aromatase, connexin 43 (Cx43) immunoexpression, Cx43 protein levels, and Cx43 expression were evaluated. Either intratesticular testosterone or estrogen levels were measured.
Results
Venlafaxine impaired sperm morphology, reduced sperm concentration, mitochondrial activity, and sperm motility. The frequency of tubules with spermiation failure and NLS increased in parallel to increased Cx43 immunoexpression; mRNA and protein levels; and aromatase, testosterone, and estrogen levels. An increase in germ cell death and decreased Sertoli cells number were observed. In venlafaxine‐65 days, except for sperm motility, mitochondrial activity, Sertoli cells number, and germ cell death, all other parameters were partially or totally recovered.
Conclusion
Venlafaxine increases testosterone aromatization and Cx43. This drug, via high estrogen levels, disturbs Sertoli cells, induces germ cell death, and impairs spermiation and sperm parameters. The restoration of spermiation associated with the decreased Cx43 and hormonal levels in venlafaxine‐65 days reinforces that high estrogen levels are related to venlafaxine‐induced changes. The presence of damaged Sertoli cells, germ cell death, and low sperm motility in venlafaxine‐65 days indicates that interruption of treatment for 30 days was insufficient for testicular recovery and points to a long‐term estrogen impact on the seminiferous epithelium.
